TABLE OF CONTENTS
Volume 17, Issue 6 (June 2003)
Reviews |
Keynote Addresses |
Original Manuscripts |
Opinions and Ideas |
Spotlight Correspondence |
Correspondence
Spotlight
In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C FREE
T Kindler, F Breitenbuecher, S Kasper, T Stevens, B Carius, H Gschaidmeier, C Huber and T Fischer
Leukemia 17: 999-1009; doi:10.1038/sj.leu.2402940
Reviews
Current CML therapy: progress and dilemma FREE
R Hehlmann
Leukemia 17: 1010-1012; doi:10.1038/sj.leu.2402951
Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects FREE
V H J van der Velden, A Hochhaus, G Cazzaniga, T Szczepanski, J Gabert and J J M van Dongen
Leukemia 17: 1013-1034; doi:10.1038/sj.leu.2402922
Keynote Addresses
Donor leukocyte infusions in acute myelogenous leukemia FREE
D L Porter
Leukemia 17: 1035-1037; doi:10.1038/sj.leu.2402950
Prevention and therapy of fungal infections in bone marrow transplantation FREE
L R Baden
Leukemia 17: 1038-1041; doi:10.1038/sj.leu.2402949
Stem cells and diversity FREE
E A McCulloch
Leukemia 17: 1042-1048; doi:10.1038/sj.leu.2402948
Diffuse alveolar hemorrhage: an evolving problem? FREE
D J Weisdorf
Leukemia 17: 1049-1050; doi:10.1038/sj.leu.2402921
Original Manuscripts
Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR FREE
D González, M González, M E Alonso, R López-Pérez, A Balanzategui, M C Chillón, M Silva, R García-Sanz and J F San Miguel
Leukemia 17: 1051-1057; doi:10.1038/sj.leu.2402937
Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia FREE
W L Blalock, P M Navolanic, L S Steelman, J G Shelton, P W Moye, J T Lee, R A Franklin, A Mirza, M McMahon, M K White and J A McCubrey
Leukemia 17: 1058-1067; doi:10.1038/sj.leu.2402925
Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells FREE
L S Metelitsa, K I Weinberg, P D Emanuel and R C Seeger
Leukemia 17: 1068-1077; doi:10.1038/sj.leu.2402943
Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia FREE
X-Y He, B Pohlman, A Lichtin, L Rybicki and M Kalaycio
Leukemia 17: 1078-1084; doi:10.1038/sj.leu.2402955
Treatment of elderly patients (
60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols FREE
F Mandelli, R Latagliata, G Avvisati, P Fazi, F Rodeghiero, F Leoni, M Gobbi, F Nobile, E Gallo, R Fanin, S Amadori, M Vignetti, G Fioritoni, F Ferrara, A Peta, R Giustolisi, G Broccia, M C Petti and F Lo-Coco for the Italian GIMEMA Cooperative Group
Leukemia 17: 1085-1090; doi:10.1038/sj.leu.2402932
High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities FREE
S Ishizawa, M L Slovak, L Popplewell, V Bedell, J E Wrede, N H Carter, D S Snyder and D A Arber
Leukemia 17: 1091-1095; doi:10.1038/sj.leu.2402918
Substance P – a potent risk factor in childhood lymphoblastic leukaemia FREE
M Nowicki and B Mi
kowiak
Leukemia 17: 1096-1099; doi:10.1038/sj.leu.2402920
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy FREE
A-M Tsimberidou, H M Kantarjian, E Estey, J E Cortes, S Verstovsek, S Faderl, D A Thomas, G Garcia-Manero, A Ferrajoli, J T Manning, M J Keating, M Albitar, S O'Brien and F J Giles
Leukemia 17: 1100-1103; doi:10.1038/sj.leu.2402958
Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases FREE
L Sanhes, R Tang, A Delmer, J A DeCaprio and F Ajchenbaum-Cymbalista
Leukemia 17: 1104-1111; doi:10.1038/sj.leu.2402895
Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis FREE
Y Qiao, S Ogawa, A Hangaishi, K Yuji, K Izutsu, A Kunisato, Y Imai, L Wang, N Hosoya, Y Nannya, Y Sato, K Maki, K Mitani and H Hirai
Leukemia 17: 1112-1120; doi:10.1038/sj.leu.2402919
PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13) FREE
S Strehl, M König, M N Dworzak, K Kalwak and O A Haas
Leukemia 17: 1121-1123; doi:10.1038/sj.leu.2402923
Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL + leukemias: incidence and underlying genetic abnormalities FREE
D Primo, M D Tabernero, A Rasillo, J M Sayagués, A B Espinosa, M C Chillón, R Garcia-Sanz, N Gutierrez, M Giralt, A Hagemeijer, J F San Miguel and A Orfao
Leukemia 17: 1124-1129; doi:10.1038/sj.leu.2402963
Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement FREE
S Viehmann, A Teigler-Schlegel, J Bruch, C Langebrake, D Reinhardt and J Harbott
Leukemia 17: 1130-1136; doi:10.1038/sj.leu.2402959
Functional characterization of human CD34+ cells that express low or high levels of the membrane antigen CD111 (nectin 1) FREE
G Belaaloui, A-M Imbert, F Bardin, C Tonnelle, P Dubreuil, M Lopez and C Chabannon
Leukemia 17: 1137-1145; doi:10.1038/sj.leu.2402916
Lack of telomerase activity in human mesenchymal stem cells FREE
S Zimmermann, M Voss, S Kaiser, U Kapp, C F Waller and U M Martens
Leukemia 17: 1146-1149; doi:10.1038/sj.leu.2402962
Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation FREE
R Schots, L Kaufman, I Van Riet, T Ben Othman, M De Waele, B Van Camp and C Demanet
Leukemia 17: 1150-1156; doi:10.1038/sj.leu.2402946
Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development FREE
T Taghon, K Thys, M De Smedt, F Weerkamp, F J T Staal, J Plum and G Leclercq
Leukemia 17: 1157-1163; doi:10.1038/sj.leu.2402947
Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt's lymphoma/leukemia cells FREE
K Mimori, N Kiyokawa, T Taguchi, T Suzuki, T Sekino, H Nakajima, M Saito, Y U Katagiri, K Isoyama, K Yamada, Y Matsuo and J Fujimoto
Leukemia 17: 1164-1174; doi:10.1038/sj.leu.2402936
Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms FREE
Y Nefedova, T H Landowski and W S Dalton
Leukemia 17: 1175-1182; doi:10.1038/sj.leu.2402924
Opinions and Ideas
Myelodysplasia – therapeutic response to novel therapy and the need for new diagnostic groups FREE
G J Schiller
Leukemia 17: 1183-1185; doi:10.1038/sj.leu.2402939
Spotlight Correspondence
Imatinib mesylate (GleevecTM) reduces phlebotomy requirements in polycythemia vera FREE
R T Silver
Leukemia 17: 1186-1187; doi:10.1038/sj.leu.2402938
Correspondence
Rare coincidence of hypertriploid chromosome number and aberrant coexpression of the lymphoid-associated antigen CD5 in acute myeloid Leukaemia FAB M0 FREE
C Kahl, A Knopp, B Steiner, M Leithäuser, S Wilhelm, H-D Kleine, D Wolff, J Casper and M Freund
Leukemia 17: 1188-1189; doi:10.1038/sj.leu.2402965
Effect of NF-
B/Rel inhibition on spontaneous vs chemotherapy-induced apoptosis in AML and normal cord blood CD34+ cells FREE
M F Romano, A Petrella, R Bisogni, M C Turco and S Venuta
Leukemia 17: 1190-1192; doi:10.1038/sj.leu.2402953
Frequencies of the major subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the West FREE
A K Siraj, S Kamat, M I Gutiérrez, S Banavali, G Timpson, S Sazawal, M Bhargava, S Advani, M Adde, I Magrath and K Bhatia
Leukemia 17: 1192-1193; doi:10.1038/sj.leu.2402931
A novel real-time RT-PCR assay for quantification of OTT-MAL fusion transcript reliable for diagnosis of t(1;22) and minimal residual disease (MRD) detection FREE
P Ballerini, A Blaise, T Mercher, B Pellegrino, C Perot, J van den Akker, E Gatbois, M Adam, L Douay, R Berger, O Bernard and J Landman-Parker
Leukemia 17: 1193-1196; doi:10.1038/sj.leu.2402914
Retention and defective assembly of the B-cell receptor in the endoplasmic reticulum of chronic lymphocytic leukaemia B cells cannot be reverted upon CD40 ligand stimulation FREE
B Payelle-Brogard, C Magnac, P Oppezzo, G Dumas, G Dighiero and F Vuillier
Leukemia 17: 1196-1199; doi:10.1038/sj.leu.2402944
Questioning the aim of CML therapy in the era of Imatinib? FREE
A M Carella
Leukemia 17: 1199-1200; doi:10.1038/sj.leu.2402954
Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome FREE
C Strupp, B Hildebrandt, U Germing, R Haas and N Gattermann
Leukemia 17: 1200-1202; doi:10.1038/sj.leu.2402894
